The Journal of Neuroscience, February 20, 2008, 28(8):1833-1840; doi:10.1523/JNEUROSCI.3222-07.2008
Previous Article | Next Article 
Neurobiology of Disease
An Aggregate-Inducing Peripherin Isoform Generated through Intron Retention Is Upregulated in Amyotrophic Lateral Sclerosis and Associated with Disease Pathology
Shangxi Xiao,1
Sonja Tjostheim,1
Teresa Sanelli,1
Jesse R. McLean,1
Patrick Horne,1
Yuxin Fan,2
John Ravits,2
Michael J. Strong,3 and
Janice Robertson1
1Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada M5S 3H2, 2Neurology Section, Neurogenomics Laboratory, Virginia Mason Medical Center, Benaroya Research Institute, Seattle, Washington 98101-2795, and 3Department of Clinical Neurological Sciences, The University of Western Ontario, London, Ontario, Canada N6A 5A5
Correspondence should be addressed to Dr. Janice Robertson, Centre for Research in Neurodegenerative Diseases, University of Toronto, Tanz Building, 6 Queen's Park Crescent West, Toronto, Ontario, Canada M5S 3H2. Email: jan.robertson{at}utoronto.ca
The neuronal intermediate filament protein peripherin is a component of ubiquitinated inclusions and of axonal spheroids in amyotrophic lateral sclerosis (ALS). Overexpression of peripherin causes motor neuron degeneration in transgenic mice and variations within the peripherin gene have been identified in ALS cases. We have shown previously the abnormal expression of a neurotoxic peripherin splice variant in transgenic mice expressing mutant superoxide dismutase-1. These findings indicated that abnormalities of peripherin splicing may occur in ALS. In the current study, peripherin splice variants were identified by reverse transcription-PCR of human neuronal RNA and comparisons in expression made between control and ALS spinal cord using Western blot analysis and immunocytochemistry. Using this approach we have identified a novel peripherin transcript retaining introns 3 and 4 that results in a 28 kDa splice isoform, designated Per 28. Using an antibody specific to Per 28, we show that this isoform is expressed at low stoichiometric levels from the peripherin gene, however causes peripherin aggregation when its expression is upregulated. Importantly we show an upregulation of Per 28 expression in ALS compared with controls, at both the mRNA and protein levels, and that Per 28 is associated with disease pathology, specifically round inclusions. These findings are the first to establish that peripherin splicing abnormalities occur in ALS, generating aggregation-prone splice isoforms.
Key words: peripherin; splice variant; isoform; ALS; intron retention; intermediate filament
Received July 16, 2007;
revised Nov. 30, 2007;
accepted Dec. 29, 2007.
Correspondence should be addressed to Dr. Janice Robertson, Centre for Research in Neurodegenerative Diseases, University of Toronto, Tanz Building, 6 Queen's Park Crescent West, Toronto, Ontario, Canada M5S 3H2. Email: jan.robertson{at}utoronto.ca
This article has been cited by other articles:

|
 |

|
 |
 
R. S. Seelan, J. Lakshmanan, M. F. Casanova, and R. N. Parthasarathy
Identification of myo-Inositol-3-phosphate Synthase Isoforms: CHARACTERIZATION, EXPRESSION, AND PUTATIVE ROLE OF A 16-kDa {gamma}c ISOFORM
J. Biol. Chem.,
April 3, 2009;
284(14):
9443 - 9457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-D. Perng, S.-F. Wen, T. Gibbon, J. Middeldorp, J. Sluijs, E. M. Hol, and R. A. Quinlan
Glial Fibrillary Acidic Protein Filaments Can Tolerate the Incorporation of Assembly-compromised GFAP-{delta}, but with Consequences for Filament Organization and {alpha}B-Crystallin Association
Mol. Biol. Cell,
October 1, 2008;
19(10):
4521 - 4533.
[Abstract]
[Full Text]
[PDF]
|
 |
|